Niranjan Kathe

578 total citations
30 papers, 396 citations indexed

About

Niranjan Kathe is a scholar working on Epidemiology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Niranjan Kathe has authored 30 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Economics and Econometrics and 5 papers in General Health Professions. Recurrent topics in Niranjan Kathe's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Microscopic Colitis (3 papers) and Cervical Cancer and HPV Research (3 papers). Niranjan Kathe is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Microscopic Colitis (3 papers) and Cervical Cancer and HPV Research (3 papers). Niranjan Kathe collaborates with scholars based in United States, Switzerland and Germany. Niranjan Kathe's co-authors include Corey J. Hayes, Nalin Payakachat, Naleen Raj Bhandari, Harsh Chauhan, Brian Henriksen, Drayton A. Hammond, Bradley C. Martin, Jacob T. Painter, Kunal Saxena and Noel T. Brewer and has published in prestigious journals such as Circulation, Medical Care and Inflammatory Bowel Diseases.

In The Last Decade

Niranjan Kathe

28 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niranjan Kathe United States 11 63 51 50 48 43 30 396
Ahmed A. Albarraq Saudi Arabia 12 42 0.7× 43 0.8× 17 0.3× 24 0.5× 18 0.4× 31 446
Rafał Staszewski Poland 12 33 0.5× 65 1.3× 14 0.3× 41 0.9× 40 0.9× 22 324
Nabeel Kashan Syed Saudi Arabia 11 19 0.3× 49 1.0× 17 0.3× 32 0.7× 15 0.3× 27 301
Bharti Kalra India 15 85 1.3× 36 0.7× 15 0.3× 62 1.3× 16 0.4× 89 833
Howard Larkin United Kingdom 8 37 0.6× 42 0.8× 7 0.1× 41 0.9× 12 0.3× 91 335
Junya Pattaraarchachai Thailand 12 136 2.2× 57 1.1× 5 0.1× 31 0.6× 32 0.7× 57 652
Holly Mansell Canada 13 29 0.5× 163 3.2× 16 0.3× 10 0.2× 29 0.7× 59 493
Kam L. Capoccia United States 7 99 1.6× 112 2.2× 15 0.3× 30 0.6× 9 0.2× 14 690
Jodi A. Cisewski United States 9 81 1.3× 83 1.6× 4 0.1× 33 0.7× 90 2.1× 12 549
Dominik Marciniak Poland 12 36 0.6× 16 0.3× 37 0.7× 38 0.8× 36 0.8× 50 446

Countries citing papers authored by Niranjan Kathe

Since Specialization
Citations

This map shows the geographic impact of Niranjan Kathe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niranjan Kathe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niranjan Kathe more than expected).

Fields of papers citing papers by Niranjan Kathe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niranjan Kathe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niranjan Kathe. The network helps show where Niranjan Kathe may publish in the future.

Co-authorship network of co-authors of Niranjan Kathe

This figure shows the co-authorship network connecting the top 25 collaborators of Niranjan Kathe. A scholar is included among the top collaborators of Niranjan Kathe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niranjan Kathe. Niranjan Kathe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Filtz, Annalisa, Niranjan Kathe, Eduard Sidelnikov, et al.. (2025). Disparities in achieving low-density lipoprotein cholesterol goals after revascularization in a diverse real-world cohort. European Journal of Preventive Cardiology. 32(13). 1192–1201. 1 indexed citations
2.
Weerasinghe, Roshanthi, Eleanor Wilson, Eduard Sidelnikov, et al.. (2024). Abstract 4136273: A Machine Learning Approach to Simplify Risk Stratification of Patients with Atherosclerotic Cardiovascular Disease. Circulation. 150(Suppl_1). 1 indexed citations
3.
Li, Hsin‐Fang, et al.. (2024). Rates of Lipid Testing among Patients with Atherosclerotic Cardiovascular Disease within a Large Community-Based Health System. Journal of clinical lipidology. 18(4). e492–e492.
4.
Cleveland, Noa Krugliak, et al.. (2024). Dose escalation of biologics in biologic-naive patients with Crohn’s disease: Outcomes from the ODESSA-CD study. Journal of Managed Care & Specialty Pharmacy. 30(11). 1276–1287.
5.
Saxena, Kunal, et al.. (2023). The Burden of Cervical Conization in Privately Insured Young and Mid-Adult Women in the United States. Vaccines. 11(4). 804–804. 2 indexed citations
6.
Khandker, Rezaul Karim, et al.. (2023). Diagnosis of behavioral symptoms as a predictor of institutionalization among Medicaid patients with dementia. BMC Geriatrics. 23(1). 807–807. 2 indexed citations
7.
Ghosh, Sabyasachi, et al.. (2023). Dose Escalation of Biologics in Biologic-Naïve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC Study. Crohn s & Colitis 360. 5(4). otad061–otad061. 3 indexed citations
8.
Saxena, Kunal, et al.. (2023). HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US. Human Vaccines & Immunotherapeutics. 19(1). 2161253–2161253. 21 indexed citations
11.
Prabhu, Vimalanand S., Niranjan Kathe, Kunal Saxena, et al.. (2021). Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States. Current Medical Research and Opinion. 37(9). 1599–1607. 5 indexed citations
12.
Kathe, Niranjan, et al.. (2019). Predictors of Cost and Incidence of 30-Day Readmissions Following Hospitalizations for Schizophrenia and Psychotic Disorders: A Nationwide Analysis. Quality Management in Health Care. 28(3). 130–138. 6 indexed citations
13.
Hammond, Drayton A., et al.. (2019). Effectiveness and Safety of Potassium Replacement in Critically Ill Patients: A Retrospective Cohort Study. Critical Care Nurse. 39(1). e13–e18. 7 indexed citations
14.
Painter, Jacob T., et al.. (2018). Consumer willingness to pay for pharmacy services: An updated review of the literature. Research in Social and Administrative Pharmacy. 14(12). 1091–1105. 16 indexed citations
15.
16.
17.
Kathe, Niranjan, Corey J. Hayes, Naleen Raj Bhandari, & Nalin Payakachat. (2017). Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population. Value in Health. 21(4). 432–440. 41 indexed citations
18.
Kathe, Niranjan, et al.. (2017). DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case–Control Study. Diabetes Therapy. 9(1). 141–151. 12 indexed citations
19.
Kathe, Niranjan, et al.. (2016). Association Between The Use Of Doxorubicin And Risk Of Developing Hepatotoxicity Among Cancer Patients. Value in Health. 19(3). A134–A134. 1 indexed citations
20.
Kathe, Niranjan, Brian Henriksen, & Harsh Chauhan. (2014). Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Development and Industrial Pharmacy. 40(12). 1565–1575. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026